Price, David BVoorham, JacoBrusselle, GuyClemens, AndreasKostikas, KonstantinosStephens, Jeffrey WPark, Hye YunRoche, NicolasFogel, Robert2020-01-072020-01-072019-10-28Price, D B, Voorham, J, Brusselle, G, Clemens, A, Kostikas, K, Stephens, J W, Park, H Y, Roche, N & Fogel, R 2019, 'Inhaled corticosteroids in COPD and onset of type 2 diabetes and osteoporosis : matched cohort study', npj Primary Care Respiratory Medicine, vol. 29, 38. https://doi.org/10.1038/s41533-019-0150-x2055-1010PubMedCentral: PMC6817865https://hdl.handle.net/2164/13464ACKNOWLEDGEMENTS We thank Derek Skinner for his contributions to the data acquisition and handling. Writing and editorial support was provided by Elizabeth V. Hillyer, DVM, supported by Novartis Pharma AG, Basel, Switzerland. This work was supported by Novartis. AUTHOR CONTRIBUTIONS All authors participated in the study design. D.B.P. and J.V. planned the analyses, and J.V. performed the analyses. All authors interpreted the findings, participated in multiple reviews of the manuscript, critically revised the manuscript, and approved the final version for submission. The data sets supporting the conclusions of this article were derived from the Clinical Practice Datalink (http://www.cprd.com) and the Optimum Patient Care Research Database (http://opcrd.co.uk/). We do not have permission to give public access to these data sets; however, researchers may request access for their own purposes.1208992engSDG 3 - Good Health and Well-beingR MedicineSupplementary DataRJournal article10.1038/s41533-019-0150-x29